Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2008
10/23/2008US20080262065 Novel inhibitors of glutaminyl cyclases
10/23/2008US20080262045 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12
10/23/2008US20080262015 therapeutically active 2,4,5-trisubstituted imidazole compounds; alone or in combination; high antineoplastic activity, low systemic toxicity and low mutagenicity on normal cells; inhibitors of p38 MAP kinase; modulators of multi-drug resistance in cancer cells
10/23/2008US20080261997 Use of aminoindazole derivatives for the inhibition of tau phosphorylation
10/23/2008US20080261990 2-({4-[((2-Furylmethyl) {[6(4-methylphenyl)pyrimidin-4-yl]methyl}amino)methyl]phenyl}thio)-2-methylpropanoic acid; dyslipidemias, arteriosclerosis, coronary heart disease, thrombosis and metabolic syndrome
10/23/2008US20080261987 Substituted piperazines
10/23/2008US20080261950 Drug hybrid of rivastigmine or physostigmine with tranylcypromine, amoxapine, desipramine, nortriptyline, protriptyline, fluoxetine, fluvoxamine, paroxetine, duloxetine, betahistine, amlodipine, proylhexedrine, rimantadine, desloratadine; Alzheimer's disease; Parkinson's disease, impairment in memory
10/23/2008US20080261947 Poly(ADP-ribose)polymerase inhibitor; ischemic diseases, cerebral infarction, antiretroviral, sensitizer for anticancer therapy, immunosuppressant; 5,6,7,8-tetrahydrophthalazin-1(2H)-one compounds; 2,3,4,6-tetrahydropyrido[2,3-d]pyridazin-5(1H)-one compounds
10/23/2008US20080261944 Indole Derivatives as Antiviral Agents
10/23/2008US20080261917 Prodrug; novel series of compounds which inhibit the MDM2-p53 interaction and have in vitro activity exerting an anti-tumour effect; cancer
10/23/2008US20080261314 Fluorescent probe for zinc
10/23/2008CA2683089A1 Benzimidazole derivatives and imidazopyridine derivatives with glucose lowering effect
10/23/2008CA2682393A1 5-membered heterocyclic derivative and use thereof for medical purposes
10/23/2008CA2682391A1 (aza)indole derivative and use thereof for medical purposes
10/23/2008CA2681311A1 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
10/22/2008EP1982984A2 Tricyclic thrombin receptor antagonists
10/22/2008EP1982982A1 Novel coumarin derivative having antitumor activity
10/22/2008EP1982978A1 Pyridone derivative and herbicide
10/22/2008EP1982976A1 Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof
10/22/2008EP1981882A1 Amide substituted quinolines
10/22/2008EP1981881A1 Tetrahydropyrane antibiotics
10/22/2008EP1981880A2 Use of 4-imidazole derivatives for cns disorders
10/22/2008EP1981879A1 Amino indazole derivatives
10/22/2008EP1981878A1 Indazole heteroaryl derivatives
10/22/2008EP1981876A1 Triazoloanilinopyrimidine derivatives for use as antiviral agents
10/22/2008EP1981874A1 Aminophenyl derivatives as novel inhibitors of histone deacetylase
10/22/2008EP1981871A1 Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase
10/22/2008EP1981865A1 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia
10/22/2008EP1981856A2 Pyrimidine derivatives
10/22/2008EP1981854A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
10/22/2008EP1981499A1 Use of 2-imidazoles for the treatment of cns disorders
10/22/2008EP1981497A2 Use of substituted 2-imidazole of imidazoline derivatives
10/22/2008EP1756089B1 Mercaptoimidazoles as ccr2 receptor antagonists
10/22/2008EP1628969A4 Benzopyran derivatives substituted with a benzimidazole derivative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
10/22/2008EP1594864B1 Benzofuran oxyethylamines serving as antidepressant drugs and anxiolytic drugs
10/22/2008EP1458394B1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3
10/22/2008EP1417196B1 Dna-pk inhibitors
10/22/2008CN101291930A Tricyclo substituted amides
10/22/2008CN101291929A Tricyclo substituted amides
10/22/2008CN101291924A Isoindole-imide compounds and compositions comprising and methods of using the same
10/22/2008CN101291923A Pyrazolone derivatives for the treatment of tuberculosis
10/22/2008CN101291922A 烷基喹啉和烷基喹唑啉类激酶调节剂 Alkyl quinoline and alkyl quinazoline kinase modulators
10/22/2008CN101291918A Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
10/22/2008CN100427486C Novel benzimidazole derivatives
10/22/2008CN100427483C Anthranilic acid amide derivatives and their pharmaceutical use
10/22/2008CN100427482C N,N-dimethylaminoacyl-2,3-difuryl-6-aminoquinoxaline, preparation method and application thereof
10/22/2008CN100427469C Quinoline derivatives as neutrophil elastase inhibitors and their use
10/21/2008US7439368 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
10/21/2008US7439367 Catalytic oxidation of sulfinyl compound; gastric ulcers; lansoprazole, omeprazole, pantoprazole, rabeprazole
10/21/2008US7439351 2′ or 3′ -deoxy and 2′, 3′-dideoxy-β-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti-viral agents
10/21/2008US7439342 Thrombopoietin mimetics
10/21/2008US7439263 e.g. 1-({[9-(hydroxymethyl)-3-oxaspiro[5.5]undec-9-yl]amino}acetyl)-2-pyrrolidinecarbonitrile; dipeptidyl-peptidase IV inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity
10/21/2008US7439258 Viral polymerase inhibitors
10/21/2008US7439249 such as 2-(7-acetylamino-1-furano-2-ylmethyl-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-succinic acid; for treatment of autoimmune diseases, proliferative diseases, angiogenic disorders, and/or cancers; catheters, prosthetics
10/21/2008US7439242 PPARγ modulators
10/21/2008US7439238 Antiparasitic artemisinin derivatives (endoperoxides)
10/21/2008CA2336624C Farnesyl protein transferase inhibitors with in vivo radiosensitizing properties
10/21/2008CA2205347C Lazaroids-based compositions and method for preventing adhesion formation using the same
10/21/2008CA2174472C Arylalkylpyridazinones
10/21/2008CA2146707C Substituted n-heteroaroylguanidines as inhibitors of na+/h+ exchange
10/16/2008WO2008124703A2 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
10/16/2008WO2008123582A1 Tetrahydroisoquinoline compound
10/16/2008WO2008123395A1 Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient
10/16/2008WO2008122510A1 1-(1-benzylpiperidin-4-yl)benzimidaz0le -5-carboxylic acid derivatives for the treatment of diabetes mellitus
10/16/2008WO2008122352A1 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors
10/16/2008WO2007105058A8 Pyrazole compounds
10/16/2008US20080255350 Substituted aza-indoles as inhibitors of poly(adp-ribose) polymerase (parp)
10/16/2008US20080255221 Novel hydroxamates as therapeutic agents
10/16/2008US20080255220 Therapeutic Substituted Gamma Lactams
10/16/2008US20080255214 Novel hydroxamates as therapeutic agents
10/16/2008US20080255207 5-Thioxo-1,5-Dihydro-2H-Pyrrol-2-One Derivatives As Liver X Receptor Modulators
10/16/2008US20080255202 Phenylthioacetic Acid Derivatives and Use Thereof
10/16/2008US20080255198 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator
10/16/2008US20080255195 Psyvhological disorders; cognition activators
10/16/2008US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread
10/16/2008US20080255167 Novel 2-Aminopyrimidine or 2-Aminiopyridinone Derivatives and Their Use
10/16/2008US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
10/16/2008US20080255152 Diaryl ethers as opioid receptor antagonists
10/16/2008US20080255146 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy
10/16/2008US20080255144 (3'-Chloro-4-methanesulfonyl-biphenyl-2-yl)-[4-(3,4-dichloro-phenyl)-piperazin-1-yl]-methanone; neurological and neuropsychiatric disorders including schizophrenia
10/16/2008US20080255143 Inhibitors of Akt Activity
10/16/2008US20080255142 Substituted Piperidine Derivatives as Somatostatin Sst1 Receptor Antagonists
10/16/2008US20080255137 N-Biaryl and N-Arylheteroaryl 2-Substituted Piperazine Derivatives as Modulators of the 5ht2c Receptor Useful for the Treatment of Disorders Related Thereto
10/16/2008US20080255136 Pyrrolidones with anti-hiv activity
10/16/2008US20080255126 Inhibitors of post-proline cleaving proteases
10/16/2008US20080255118 Cyanopyrimidinones
10/16/2008US20080255117 Sulfonyltryptophanols
10/16/2008US20080255116 Therapy for bacteria infections other than Mycibacterium infections; antibiotic resistance
10/16/2008US20080255113 N-({1-[(cis-1,4-dihydroxycyclohexyl)methyl]piperidin-4-yl}methyl)-1-isopropyl-5-methyl-2-oxo-1, 2-dihydroquinoline-3-carboxamide ethanedioate; gastroesophageal reflux disease, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome
10/16/2008US20080255109 Antigonadotrophins; breast and prostate cancer, endometriosis, benign prostate hyperplasia; regulation of fertility; 4-(3-Chloro-4-{{(4-chloro-benzenesulfonyl)-methyl-amino]-methyl}-thiophene-2-carbonyl)-3,4-dihydro-2H-benzo[1,4]oxazine-2carboxylic acid (3-methyl-[1,2,4]oxadiazol-5-ylmethyl)-amide
10/16/2008CA2683434A1 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
10/16/2008CA2682875A1 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors
10/16/2008CA2682287A1 1-(1-benzylpiperidin-4-yl)benzimidaz0le -5-carboxylic acid derivatives for the treatment of diabetes mellitus
10/16/2008CA2680838A1 Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitory effect as active ingredient
10/15/2008EP1980560A2 C-glycoside derivatives for the treatment of diabetes
10/15/2008EP1979331A1 Trisubstituted amine compounds as inhibitors of -cholesteryl ester transfer protein cetp
10/15/2008EP1979329A2 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and methods of use
10/15/2008EP1979328A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
10/15/2008EP1979325A1 Morpholino pyrimidine derivatives and their use in therapy
10/15/2008EP1979324A2 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer's disease, neurodegeneration and dementia
1 ... 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 ... 694